Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10483399 | Research Policy | 2005 | 11 Pages |
Abstract
This paper analyses the role of repeated ties in the high-tech pharmaceutical biotechnology industry, a sector that is characterized by a strong dual market structure. Our most important finding is that previous ties in pairs of large pharmaceutical companies and small biotechnology firms have a negative effect on their subsequent partnering. An explanation for this result is found in the context of understanding the specifics of large-small coalitions in a high-tech dual market structure. Unlike what is known about repeated ties in many other industries, this high-tech dual market structure indicates that R&D partnerships between a small number of very large companies and a large group of dependent, small firms are not characterized by mutual dependence, similarity, or equality.
Related Topics
Social Sciences and Humanities
Business, Management and Accounting
Business and International Management
Authors
Nadine Roijakkers, John Hagedoorn, Hans van Kranenburg,